Asian Science
Citation Index is committed to provide an authoritative, trusted
and significant information by the coverage of the most important
and influential journals to meet the needs of the global scientific
community.
Abstract: Type II diabetes mellitus (T2DM) patients have increased risk for atherosclerotic cardiovascular disease (CVD), which is partly attributable to dyslipidemia. Although statins are the recommended therapeutic strategy, fenofibrate (FFB)-known to decrease TG levels, increase HDL-C, and shift the distribution of LDL subfractions towards larger, less atherogenic particles-has been recommended as adjuvant therapy with statins.
